Shell Tianjin Investment Co., Ltd. increased its capital to 600 million US dollars. Tianyancha App shows that recently, Shell Tianjin Investment Co., Ltd. has undergone industrial and commercial changes, and its registered capital has increased from 550 million US dollars to 600 million US dollars. The company was established in September 2018, and its legal representative is Peng Yongdong, which is wholly owned by Hongkong Enjoying International Limited.Brian Sun, Director of the Arms Control Department of the Ministry of Foreign Affairs, met with Zaka, Director of the International Security and Disarmament Department of the Ministry of Foreign Affairs of Indonesia. On December 10, 2024, Brian Sun, Director of the Arms Control Department of the Ministry of Foreign Affairs, met with Zaka, Director of the International Security and Disarmament Department of the Ministry of Foreign Affairs of Indonesia. The two sides exchanged views on the international and regional security situation, non-proliferation export control and other issues.Vegetable oil rose by 2.08% on the 11th, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract vegetable oil closed at 2,505, up or down by +2.08%, with a turnover of 727,500 lots. The position data showed that the top 20 seats were net, and the difference position was 2,628 lots. The total turnover of vegetable oil futures contracts was 857,200 lots, an increase of 255,300 lots over the previous day. The first 20 seats in the contract held 240,200 lots, an increase of 6,901 lots over the previous day. The short positions in the top 20 seats of the contract were 239,200 lots, a decrease of 1,059 lots from the previous day. (Sina Futures)
Kanglongda: The company's products have not been directly sold to humanoid robots and aerospace manufacturing-related enterprises. Kanglongda said on the interactive platform on December 11 that the ultra-high molecular weight polyethylene (UHMWPE) fibers produced by the company are mainly used for industrial synergy, and the products sold abroad are mainly used in the fields of national defense and police, rope nets and belts. Up to now, the company's products have not been directly sold to humanoid robots and aerospace manufacturing related enterprises.Nissan Motor Co., Ltd. reorganized its top management: CFO will be transferred to China to take charge of operations, and Nissan Motor Co., Ltd. is reorganizing its top management, hoping to introduce new talents and reverse the company's declining profits, increasing debts and lack of revenue-generating products. Makoto Uchida will continue to be the CEO of Nissan, while Jeremie Papin will be the CFO at the end of next year, and Christian Meunier will succeed Papin as the chairman of Nissan Americas. In addition, Stephen Ma, the company's chief financial officer, will be transferred to China to take charge of local business operations.Ding Xiaoqiang was appointed as a member, standing committee member and secretary of Changzhi Municipal Committee. According to the news of Changzhi News VideoNo. on December 11th, Changzhi held a meeting of leading cadres in the whole city. The meeting announced the decision of the provincial party committee, and Comrade Ding Xiaoqiang was appointed as a member, standing committee member and secretary of Changzhi Municipal Committee.
The Ukrainian military said it attacked the oil depot in the Bryansk region of Russia.Changhong Meiling: It plans to use its own idle funds not exceeding 6.35 billion yuan to invest in wealth management products. Changhong Meiling announced that in order to improve the efficiency of the company's use of funds, increase the company's cash assets income, and maximize the interests of shareholders, the company and its subsidiaries (excluding Zhongke Meiling Cryogenic Technology Co., Ltd. and its subsidiaries) will use their own idle funds not exceeding 6.35 billion yuan (this amount can be used in a rolling way) to invest and purchase products with high safety, good liquidity and a term of less than one year.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.
Strategy guide
12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13